Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism in vitro and in vivo

As a novel acid-suppressing drug, vonoprazan shows the potential to replace traditional proton-pump inhibitors. With its widespread use, some adverse effects that require further study have emerged due to drug–drug interactions. Our study is the first experiment that evaluated the drug–drug interact...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiran, Shi, Jihua, Dai, Dapeng, Cai, Jianping, Wang, Shuanghu, Hong, Yun, Zhou, Shan, Zhao, Fangling, Zhou, Quan, Geng, Peiwu, Zhou, Yunfang, Xu, Xue, Luo, Qingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424819/
https://www.ncbi.nlm.nih.gov/pubmed/36052128
http://dx.doi.org/10.3389/fphar.2022.909168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424819/
https://www.ncbi.nlm.nih.gov/pubmed/36052128
http://dx.doi.org/10.3389/fphar.2022.909168

Ejemplares similares